IQVIA_Rules_Based_Medicine_Logo - rgb

(+01) 512 835 8026

Email us

Type your search term and press "enter."

Trefoil Factor 3

Trefoil Factor 3

Trefoil factor 3 (TFF3) or intestinal trefoil factor, belongs to a small family of three mucin-associated peptides (TFF1, TFF2, and TFF3). TFF3 exists in a 60-amino acid monomeric form (6.7 kDa) and a 118-amino acid dimeric form (13.1 kDa). Under normal conditions TFF3 is expressed by goblet cells of the intestine and the colon. TFF3 expression was found in human respiratory tract, human goblet cells, and in human salivary gland. In addition, TFF3 peptide was found in human hypothalamus. Elevation of TFF3 in plasma and urine has been associated with certain types of kidney damage.

Swiss-Prot Accession Number: Q07654


Bibliography

Biomarker panels associated with progression of renal disease in type 1 diabetes. (2019) Colombo M, Valo E, McGurnaghan SJ, Sandholm N, Blackbourn LAK, Dalton RN, Dunger D, Groop PH, McKeigue PM, Forsblom C, Colhoun HM Diabetologia

medical_services Therapy Indications

Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology (2019) Meyer PF, Savard M, Poirier J, Morgan D, Breitner J, for the Alzheimers Disease Neuroimaging Initiative Alzheimers & Dementia

medical_services Therapy Indications

Perspectives on using a multiplex human kidney safety biomarker panel to detect cisplatin-induced tubular toxicity in male and female Cynomolgus monkeys. (2017) Chen Y, Dale Thurman J, Kinter LB, Bialecki R, Eric McDuffie J Toxicol Appl Pharmacol.

medical_services Therapy Indications

Plasma biomarkers of depressive symptoms in older adults (2012) Arnold SE, Xie SX, Leung YY, Wang LS, Kling MA, Han X, Kim EJ, Wolk DA, Bennett DA, Chen-Plotkin A, Grossman M, Hu W, Lee VMY, Mackin RS, Trojanowski JQ, Wilson RS, Shaw LM Translational Psychiatry (2012) 2, e65;

medical_services Therapy Indications

Trefoil Factor 3 Predicts Incident Chronic Kidney Disease: A Case-Control Study Nested within the Atherosclerosis Risk in Communities (ARIC) Study (2011) Astor BC, K?ttgen A, Hwang SJ, Bhavsar N, Fox CS, Coresh J Am J Nephrol. 2011 Aug 9;34(4):291-297.

medical_services Therapy Indications

A guidance for renal biomarker lead optimization and use in translational pharmacodynamics (2010) Ozer JS Drug Discov Today15: 142-7.

medical_services Therapy Indications